NRIX - Nurix Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$34.67
DETAILS
HIGH:
$45.00
LOW:
$28.00
MEDIAN:
$34.00
CONSENSUS:
$34.67
UPSIDE:
33.14%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-01 | Hansen Gwenn | officer: Chief Scientific Officer | M-Exempt | 1,452 | $1.86 | $3K |
| 2026-09-01 | Hansen Gwenn | officer: Chief Scientific Officer | SELL | 1,452 | $25.47 | $37K |
| 2026-08-05 | Hansen Gwenn | officer: Chief Scientific Officer | SELL | 4,356 | $25.00 | $109K |
| 2026-08-04 | Hansen Gwenn | officer: Chief Scientific Officer | SELL | 1,500 | $23.87 | $36K |
| 2026-08-04 | Hansen Gwenn | officer: Chief Scientific Officer | SELL | 2,611 | $24.64 | $64K |
| 2026-08-05 | Hansen Gwenn | officer: Chief Scientific Officer | M-Exempt | 4,356 | $1.86 | $8K |
| 2026-08-04 | van Houte Hans | officer: Chief Financial Officer | SELL | 1,794 | $23.89 | $43K |
| 2026-08-04 | van Houte Hans | officer: Chief Financial Officer | SELL | 2,967 | $24.65 | $73K |
| 2026-08-03 | Ring Christine | officer: Chief Legal Officer | M-Exempt | 5,787 | $8.72 | $50K |
| 2026-08-03 | Ring Christine | officer: Chief Legal Officer | SELL | 16,589 | $23.05 | $382K |
| 2026-07-30 | Hansen Gwenn | officer: Chief Scientific Officer | M-Exempt | 3,572 | -- | -- |
| 2026-07-30 | van Houte Hans | officer: Chief Financial Officer | SELL | 2,845 | $23.38 | $67K |
| 2026-07-30 | Ring Christine | officer: Chief Legal Officer | M-Exempt | 3,572 | -- | -- |
| 2026-07-30 | Ring Christine | officer: Chief Legal Officer | M-Exempt | 3,750 | -- | -- |
| 2026-07-30 | van Houte Hans | officer: Chief Financial Officer | M-Exempt | 3,572 | -- | -- |
| 2026-07-30 | van Houte Hans | officer: Chief Financial Officer | M-Exempt | 2,858 | -- | -- |
| 2026-07-30 | Hansen Gwenn | officer: Chief Scientific Officer | M-Exempt | 2,858 | -- | -- |
| 2026-07-30 | Ring Christine | officer: Chief Legal Officer | M-Exempt | 2,858 | -- | -- |
| 2026-07-30 | Ring Christine | officer: Chief Legal Officer | SELL | 3,847 | $23.38 | $90K |
| 2026-07-30 | Hansen Gwenn | officer: Chief Scientific Officer | SELL | 3,847 | $23.38 | $90K |
| 2026-07-30 | Hansen Gwenn | officer: Chief Scientific Officer | M-Exempt | 3,750 | -- | -- |
| 2026-07-30 | van Houte Hans | officer: Chief Financial Officer | M-Exempt | 3,750 | -- | -- |
| 2026-07-02 | Ring Christine | officer: Chief Legal Officer | M-Exempt | 5,787 | $8.72 | $50K |
| 2026-07-02 | Ring Christine | officer: Chief Legal Officer | M-Exempt | 5,221 | $1.86 | $10K |
| 2026-07-02 | Ring Christine | officer: Chief Legal Officer | SELL | 11,008 | $23.56 | $259K |